Read the original here:
ONO Receives a Manufacturing and Marketing Approval of Adlumiz® (Anamorelin), a Ghrelin Receptor Agonist for the Treatment of Cancer Cachexia in...

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh